dolasetron has been researched along with Bilateral Headache in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (66.67) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wilkes, G | 1 |
| Catimel, G; Clavel, M; Dumortier, A; Guastalla, JP; Merrouche, Y; O'Grady, P; Rebattu, P | 1 |
| Chemaissani, A; Cognetti, F; Conte, PF; Cortes-Funes, H; Del Favero, A; Diaz-Rubio, E; Dressler, H; Duclos, B; Fauser, AA | 1 |
| Alberts, DS; Bertoli, L; Cramer, MB; Eisenberg, P; Hahne, WF; Khojasteh, A; Modiano, MR; Plezia, P; Yeilding, A | 1 |
| Bastit, P; Cals, L; Cappelaere, P; Catimel, G; Chevallier, B; Claverie, N; Fabbro, M; Giovannini, M; Khayat, D; Splinter, T; Wendling, JL | 1 |
| Chelly, JE; Diemunsch, P; DuBois, DM; Kovac, AL; McKenzie, R; McLeskey, CH; Philip, BK | 1 |
5 trial(s) available for dolasetron and Bilateral Headache
| Article | Year |
|---|---|
A phase I antiemetic study of MDL 73,147EF, a novel 5-hydroxytryptamine antagonist in cancer patients receiving emetogenic chemotherapy.
Topics: Adult; Aged; Antiemetics; Antineoplastic Agents; Diarrhea; Female; Headache; Humans; Indoles; Male; Middle Aged; Nausea; Neoplasms; Quinolizines; Serotonin Antagonists; Vomiting | 1994 |
Therapeutic equivalence of single oral doses of dolasetron mesilate and multiple doses of ondansetron for the prevention of emesis after moderately emetogenic chemotherapy. European Dolasetron Comparative Study Group.
Topics: Adult; Aged; Analysis of Variance; Antiemetics; Antineoplastic Agents; Dose-Response Relationship, Drug; Double-Blind Method; Female; Headache; Humans; Indoles; Logistic Models; Male; Middle Aged; Nausea; Neoplasms; Ondansetron; Patient Satisfaction; Quinolizines; Risk Factors; Therapeutic Equivalency; Vomiting | 1996 |
Antiemetic efficacy of two different single intravenous doses of dolasetron in patients receiving high-dose cisplatin-containing chemotherapy.
Topics: Antiemetics; Antineoplastic Agents; Blood Pressure; Cisplatin; Diarrhea; Double-Blind Method; Drug Tolerance; Electrocardiography; Female; Headache; Heart Rate; Humans; Indoles; Injections, Intravenous; Male; Middle Aged; Patient Satisfaction; Quinolizines; Remission Induction; Safety; Vomiting | 1996 |
A double-blind, multicentre comparison of intravenous dolasetron mesilate and metoclopramide in the prevention of nausea and vomiting in cancer patients receiving high-dose cisplatin chemotherapy.
Topics: Acute Disease; Alcoholism; Antiemetics; Antineoplastic Agents; Basal Ganglia Diseases; Cisplatin; Double-Blind Method; Female; Headache; Humans; Indoles; Injections, Intravenous; Male; Metoclopramide; Middle Aged; Nausea; Neoplasms; Patient Satisfaction; Quinolizines; Remission Induction; Safety; Serotonin Antagonists; Sex Factors; Vomiting | 1997 |
Pooled analysis of three large clinical trials to determine the optimal dose of dolasetron mesylate needed to prevent postoperative nausea and vomiting. The Dolasetron Prophylaxis Study Group.
Topics: Adult; Analysis of Variance; Anesthesia, General; Antiemetics; Bradycardia; Chi-Square Distribution; Double-Blind Method; Electrocardiography; Female; Follow-Up Studies; Headache; Humans; Indoles; Intraoperative Care; Logistic Models; Male; Placebos; Postoperative Nausea and Vomiting; Quinolizines; Safety; Sex Factors; Time Factors | 2000 |
1 other study(ies) available for dolasetron and Bilateral Headache
| Article | Year |
|---|---|
Antiemetic agents.
Topics: Administration, Oral; Anorexia; Antiemetics; Antineoplastic Agents; Aprepitant; Asthenia; Constipation; Diarrhea; Drug Interactions; Dyspepsia; Fatigue; Fever; Granisetron; Headache; Hiccup; Humans; Indoles; Injections, Intravenous; Isoquinolines; Morpholines; Nausea; Neoplasms; Ondansetron; Palonosetron; Quinolizines; Quinuclidines; Vomiting | 2007 |